Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (10): 1000-1004.doi: 10.3736/jcim20081003

• Original Clinical Research • Previous Articles     Next Articles

Effects of Ru'ai Shuhou Recipe on 5-year recurrence rate after mastectomy in breast cancer

Sheng Liu1(), Jing Zhao1, Jia Liu2, Zhen-ping Sun1, Yong-qiang Hua1, De-ming Lu1, Han-jun Tang1   

  1. 1. Department of Breast Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
    2. Department of Thoracic Surgery, Tumor Hospital of Shaanxi Province, Xi'an, Shaanxi Province 710061, China
  • Received:2008-04-22 Online:2008-10-20 Published:2008-10-15

Objective: To observe the effects of Ru'ai Shuhou Recipe (RSR), a compound traditional Chinese herbal medicine, on 5-year recurrence rate after mastectomy in breast cancer.
Methods: A total of 300 patients with breast cancer were divided into two groups: treatment group and control group. The patients in the treatment group were treated with Western medicine and RSR, and the patients in the control group were treated only with Western medicine (the same as the treatment group). In the two groups, the 5-year recurrence rates after mastectomy in breast cancer were investigated.
Results: Thirty-four breast cancer patients were lost to five-year follow-up during the course of investigation, and 266 breast cancer patients went through the evaluation. The 5-year recurrence rate after mastectomy in the treatment group was significantly lower than that in the control group (P<0.05). The recurrence rate after mastectomy was influenced by positive lymph node, primary breast tumor size, clinical stage, and patients' health status. There was significant difference in the 5-year recurrence rates between the two groups (P<0.05) under the following conditions, such as the positive lymph nodes more than four, the primary breast tumor larger than two centimeters, and in the clinical stage Ⅱ and Ⅲ, estrogen receptor (ER)-positive/progesterone receptor (PR)-positive and ER-negative/PR-negative. The recurrence rate was not associated with the operation method and age distribution.
Conclusion: RSR can reduce the 5-year recurrence rate after mastectomy in breast cancer.

Key words: breast cancer, recurrence, metastasis, Ruai Shuhou Recipe, traditional Chinese medicine

CLC Number: 

  • R737.9
[1] Shen ZZ, Shao ZM. Breast oncology[M]. Shanghai: Shanghai Scientific and Technical Publishers,2005: 115-289
沈镇宙, 邵志敏 . 乳腺肿瘤学[M]. 上海: 上海科学技术出版社,2005: 115-289
[2] Li SL. Breast oncology[M]. Beijing: Scientific and Technical Documents Publishing House,2000: 391-396
李树玲 . 乳腺肿瘤学[M]. 北京: 科学技术文献出版社,2000: 391-396
[3] Lin JL, Li LQ, Sai YD , et al. Application of COX model for evaluation of the prognostic factors in patients with breast cancer[J]. Guangxi Yi Xue, 1993,15(6):495
林进令, 黎乐群, 赛义德 , 等. COX 模型在影响乳腺癌术后预后因素分析中的应用[J]. 广西医学, 1993,15(6):495
[4] Liu M, Liu XY, Xing SQ . Influencing factors for breast cancer recurrence and metastasis after mastectomy[J]. Zhonghua Zhong Liu Za Zhi, 1993,15(2):133
刘明, 刘晓颖, 邢树乔 . 影响乳腺癌术后复发及转移的因素[J]. 中华肿瘤杂志, 1993,15(2):133
[5] Lu CL . Cause of postoperative local recurrence and the treatment for breast cancer[J]. Zhong Liu Xue Za Zhi, 2005,11(5):385-387
doi: 10.3969/j.issn.1671-170X.2005.05.024
卢崇亮 . 乳腺癌术后局部复发原因及其治疗[J]. 肿瘤学杂志, 2005,11(5):385-387
doi: 10.3969/j.issn.1671-170X.2005.05.024
[6] Tang P, Jiang J, Yang XH , et al. Clinical and pathological influencing factors for breast cancer recurrence and metastasis after mastectomy[J]. Di San Jun Yi Da Xue Xue Bao, 2007,29(11):1099-1101
唐鹏, 姜军, 杨新华 , 等. 影响乳腺癌改良根治术后复发转移的临床病理因素分析[J]. 第三军医大学学报, 2007,29(11):1099-1101
[7] Li G, Ning LS . Clinical research on ER, PR status with recurrence and distant metastatic site in primary breast cancer[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2006,13(3):187-189
doi: 10.3969/j.issn.1673-5269.2006.03.008
李刚, 宁连胜 . 雌孕激素受体与女性原发乳腺癌术后复发转移关系的临床研究[J]. 中华肿瘤防治杂志, 2006,13(3):187-189
doi: 10.3969/j.issn.1673-5269.2006.03.008
[8] Que HF, Wu XQ, Chen QJ . Lu Deming's experience on therapy for strengthening healthy energy in preventing and treating the recurrence and metastasis of breast cancer[J]. Liaoning Zhong Yi Za Zhi, 1998,25(7):297-298
阙华发, 吴雪卿, 陈前军 . 陆德铭扶正法为主防治乳腺癌复发转移的经验[J]. 辽宁中医杂志, 1998,25(7):297-298
[9] Wan H, Wu XQ, Lu DM . Application of method to support anti-pathogenic ability and expel pathogens in the treatment of mammary cancer[J]. Shanghai Zhong Yi Yao Da Xue Xue Bao, 2002,16(1):30-31
doi: 10.3969/j.issn.1008-861X.2002.01.010
万华, 吴雪卿, 陆德铭 . 扶正祛邪在治疗乳腺癌中的运用[J]. 上海中医药大学学报, 2002,16(1):30-31
doi: 10.3969/j.issn.1008-861X.2002.01.010
[10] Tang HJ . Brief on clinical and experimental study of mammary cancer[J]. Zhong Yi Yao Xue Kan, 2003,21(2):168-172
doi: 10.3969/j.issn.1673-7717.2003.02.002
唐汉钧 . 乳腺癌的中医临床与实验研究[J]. 中医药学刊, 2003,21(2):168-172
doi: 10.3969/j.issn.1673-7717.2003.02.002
[11] Lin Y, Tang HJ. Contemporary Chinese medicine in breast disease[M]. Beingjing: People's Medical Publishing House,2003: 185-189
林毅, 唐汉钧 . 现代中医乳房病学[M]. 北京: 人民卫生出版社,2003: 185-189
[12] Lu DM . Qi-enriching and yin-nourishing as major therapy in treatment of breast carcinoma after operation[J]. Shanghai Zhong Yi Yao Da Xue Xue Bao, 2008,22(1):1-3
doi: 10.3969/j.issn.1008-861X.2008.01.001
陆德铭 . 益气养阴法为主调治乳腺癌术后患者[J]. 上海中医药大学学报, 2008,22(1):1-3
doi: 10.3969/j.issn.1008-861X.2008.01.001
[13] Wan H, Wu XQ, Liu S . Clinical study on the impact of "Ru'ai shu hou herbs" on life quality in breast cancer patients[J]. Shanghai Zhong Yi Yao Za Zhi, 2004,38(9):28-31
万华, 吴雪卿, 刘胜 . “乳癌术后方”对乳腺癌患者生活质量影响的临床研究[J]. 上海中医药杂志, 2004,38(9):28-31
[14] Chen QJ, Situ HL, Lu DM , et al. Clinical observation of RuningⅡin inhibiting recurrence and metastasis of breast cancer[J]. Xian Dai Zhong Xi Yi Jie He Za Zhi, 2002,11(16):1546-1548
陈前军, 司徒红林, 陆德铭 , 等. 乳宁Ⅱ号抗乳腺癌短期复发转移的临床研究[J]. 现代中西医结合杂志, 2002,11(16):1546-1548
[15] Weng ZY, Quan ZW, Wu KJ . Progress of surgical treatment for breast cancer[J]. Shanghai Di Er Yi Ke Da Xue Xue Bao, 2001,21(1):93-96
翁子毅, 全志伟, 吴克瑾 . 乳腺癌外科治疗进展[J]. 上海第二医科大学学报, 2001,21(1):93-96
[1] Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[2] Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.
[3] Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.
[4] Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.
[5] Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[6] Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64.
[7] Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477.
[8] Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394.
[9] Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438.
[10] Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294.
[11] Thomas Efferth, An-long Xu, Roxana Damiescu, Mita Banerjee, Norbert W. Paul, David Y.W. Lee. Can eastern wisdom resolve western epidemics? Traditional chinese medicine therapies and the opioid crisis. Journal of Integrative Medicine, 2021, 19(4): 295-299.
[12] Si-qi Tang, Yun-liang Wang, Zi-ye Xie, Yang Zhang, Yi Guo, Kang-li Gao, Tang-you Mao, Chun-e Xie, Jun-xiang Li, Xiao-yan Gao. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome. Journal of Integrative Medicine, 2021, 19(3): 274-281.
[13] Miao-yan Shi, Shi-qi Sun, Wei Zhang, Xing Zhang, Gui-hua Xu, Xuan Chen, Zi-jian Su, Xiu-ming Song, Lu-jiong Liu, Yi-bao Zhang, Yi-le Zhang, Meng Sun, Qi Chen, Yan Xue, Hua Lü, Wei-an Yuan, Xiao-rong Chen, Yun-fei Lu. Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: a retrospective cohort study. Journal of Integrative Medicine, 2021, 19(3): 226-231.
[14] Shu-jun Wei, Qing-man He, Qing Zhang, Kang-hua Fu, Ruo-lan Li, Wei Peng, Yong-xiang Gao. Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review. Journal of Integrative Medicine, 2021, 19(3): 191-202.
[15] Yi Xia, Lu-shao-bo Shi, Jing-hui Chang, Hua-zhang Miao, Dong Wang. Impact of the COVID-19 pandemic on intention to use traditional Chinese medicine: A cross-sectional study based on the theory of planned behavior. Journal of Integrative Medicine, 2021, 19(3): 219-225.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228